Details for Patent: 12,678,504
✉ Email this page to a colleague
Which drugs does patent 12,678,504 protect, and when does it expire?
Patent 12,678,504 protects XELSTRYM and is included in one NDA.
This patent has eleven patent family members in nine countries.
Drugs Protected by US Patent 12,678,504
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Noven Pharms Inc | XELSTRYM | dextroamphetamine | SYSTEM;TRANSDERMAL | 215401-001 | Mar 22, 2022 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | METHOD OF TRANSDERMALLY ADMINISTERING DEXTROAMPHETAMINE | ⤷ Start Trial | |||
| Noven Pharms Inc | XELSTRYM | dextroamphetamine | SYSTEM;TRANSDERMAL | 215401-002 | Mar 22, 2022 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | METHOD OF TRANSDERMALLY ADMINISTERING DEXTROAMPHETAMINE | ⤷ Start Trial | |||
| Noven Pharms Inc | XELSTRYM | dextroamphetamine | SYSTEM;TRANSDERMAL | 215401-003 | Mar 22, 2022 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | METHOD OF TRANSDERMALLY ADMINISTERING DEXTROAMPHETAMINE | ⤷ Start Trial | |||
| Noven Pharms Inc | XELSTRYM | dextroamphetamine | SYSTEM;TRANSDERMAL | 215401-004 | Mar 22, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | METHOD OF TRANSDERMALLY ADMINISTERING DEXTROAMPHETAMINE | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,678,504
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 095260 | ⤷ Start Trial | |||
| Australia | 2014235057 | ⤷ Start Trial | |||
| Canada | 2905907 | ⤷ Start Trial | |||
| European Patent Office | 2968198 | ⤷ Start Trial | |||
| Spain | 2702879 | ⤷ Start Trial | |||
| Hong Kong | 1220608 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
